Gabay Avraham
SEC CIK 1777328 · EDGAR
BoughtSold
Most active insiders at LFWD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zamir Haggai | Dir | — | — |
| 2 | Greenwald Yonason | Dir | — | — |
| 3 | Rose Keith Dale | Chief Medical Off | — | — |
| 4 | Sigsbee William Mark | Dir | — | — |
| 5 | Rozenbaum Moshe H | Dir | — | — |
| 6 | Reznick Yehuda | Dir | — | — |
| 7 | Lynch Jeannine | VP of Market Access, Strategy | — | — |
| 8 | Gabay Avraham | Dir | — | — |
| 9 | Kidron Miriam | Dir | — | — |
| 10 | KIDRON NADAV | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 17:08 | 2026-08-20 | LFWD | Lifeward Ltd. | Gabay Avraham | Dir | A - Grant | $0.00 | +13.6K | 13.6K | New | $0 | |
| 2026-07-02 17:00 | 2026-07-01 | ORMP | ORAMED PHARMACEUTICALS INC. | Gabay Avraham | CFO | S - Sale | $4.51 | -73.4K | 671.8K | -10% | -$330.7K | |
| 2026-03-18 | 2026-03-17 | ORMP | ORAMED PHARMACEUTICALS INC. | Gabay Avraham | CFO | A - Grant | $0.00 | +95.9K | 745.1K | +15% | $0 | |
| D | 2026-01-29 | 2026-01-22 | ORMP | ORAMED PHARMACEUTICALS INC. | Gabay Avraham | CFO | M - OptEx | $0.00 | +19.0K | 649.3K | +3% | $0 |
| DM | 2026-01-02 | 2025-12-31 | ORMP | ORAMED PHARMACEUTICALS INC. | Gabay Avraham | CFO | A - Grant | $0.00 | +196.2K | 515.3K | +62% | $0 |
| M | 2025-02-11 | 2025-02-11 | ORMP | ORAMED PHARMACEUTICALS INC. | Gabay Avraham | CFO | A - Grant | $0.00 | +76.0K | 434.0K | +21% | $0 |
| 2025-01-06 | 2025-01-02 | ORMP | ORAMED PHARMACEUTICALS INC. | Gabay Avraham | CFO | A - Grant | — | +188.0K | 358.0K | +111% | — | |
| 2024-11-08 | 2024-11-07 | ORMP | ORAMED PHARMACEUTICALS INC. | Gabay Avraham | CFO | A - Grant | — | +30.0K | 170.0K | +21% | — | |
| 2024-06-21 | 2024-06-21 | ORMP | ORAMED PHARMACEUTICALS INC. | Gabay Avraham | CFO | A - Grant | — | +140.0K | 0 | New | — |
Purchase Sale Sale after option exercise All abbreviations